{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:39:35Z","timestamp":1790995175991,"version":"4.1.0"},"reference-count":111,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Rationale<\/jats:title>\n<jats:p>Methamphetamine use and related harms have risen at alarming rates. While several psychosocial and pharmacologic interventions have been described in the literature, there is uncertainty regarding the best approach for the management of methamphetamine use disorder (MUD) and problematic methamphetamine use (PMU). We conducted a scoping review of recent systematic reviews (SR), clinical practice guidelines (CPG), and primary controlled studies of psychosocial and pharmacologic treatments for MUD\/PMU.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Guided by an a priori protocol, electronic database search updates (e.g., MEDLINE, Embase) were performed in February 2022. Screening was performed following a two-stage process, leveraging artificial intelligence to increase efficiency of title and abstract screening. Studies involving individuals who use methamphetamine, including key subgroups (e.g. those with mental health comorbidities; adolescents\/youths; gay, bisexual, and other men who have sex with men) were sought. We examined evidence related to methamphetamine use, relapse, use of other substances, risk behaviors, mental health, harms, and retention. Figures, tables and descriptive synthesis were used to present findings from the identified literature.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>We identified 2 SRs, one CPG, and 54 primary studies reported in 69 publications that met our eligibility criteria. Amongst SRs, one concluded that psychostimulants had no effect on methamphetamine abstinence or treatment retention while the other reported no effect of topiramate on cravings. The CPG strongly recommended psychosocial interventions as well as self-help and family support groups for post-acute management of methamphetamine-related disorders. Amongst primary studies, many interventions were assessed by only single studies; contingency management was the therapy most commonly associated with evidence of potential effectiveness, while bupropion and modafinil were analogously the most common pharmacologic interventions. Nearly all interventions showed signs of potential benefit on at least one methamphetamine-related outcome measure.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Discussion<\/jats:title>\n<jats:p>This scoping review provides an overview of available interventions for the treatment of MUD\/PMU. As most interventions were reported by a single study, the effectiveness of available interventions remains uncertain. Primary studies with longer durations of treatment and follow-up, larger sample sizes, and of special populations are required for conclusive recommendations of best approaches for the treatment of MUD\/PMU.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0292745","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T17:32:44Z","timestamp":1697045564000},"page":"e0292745","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Psychosocial and pharmacologic interventions for problematic methamphetamine use: Findings from a scoping review of the literature"],"prefix":"10.1371","volume":"18","author":[{"given":"Mona","family":"Hersi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Corace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candyce","family":"Hamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Esmaeilisaraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Dryburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8293-9238","authenticated-orcid":true,"given":"Becky","family":"Skidmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Garber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Porath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Willows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"MacPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Sproule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Flores-Aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandlee","family":"Dickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5662-8647","authenticated-orcid":true,"given":"Brian","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,10,11]]},"reference":[{"key":"pone.0292745.ref001","unstructured":"Canadian Centre on Substance Use and Addiction. Methamphetamine. 2020. Available: https:\/\/www.ccsa.ca\/sites\/default\/files\/2020-03\/CCSA-Canadian-Drug-Summary-Methamphetamine-2020-en.pdf"},{"key":"pone.0292745.ref002","unstructured":"Canadian Center on Susbstance use and Addiction. Methamphetamine. Canadian Centre on Substance Abuse; 2018. Available: https:\/\/www.ccsa.ca\/sites\/default\/files\/2019-04\/CCSA-Canadian-Drug-Summary-Methamphetamine-2018-en.pdf"},{"key":"pone.0292745.ref003","article-title":"Pilot project report: survey on drug use among harm reduction clients","author":"M Kuo","year":"2012","journal-title":"British Columbia Center for Disease Control"},{"key":"pone.0292745.ref004","volume-title":"What is the scope of methamphetamine use in the United States?","author":"National Institute on Drug Abuse","year":"2023"},{"key":"pone.0292745.ref005","volume-title":"Trends in U.S. methamphetamine use and associated deaths","author":"NIH Research Matters","year":"2021"},{"key":"pone.0292745.ref006","volume-title":"Signals of spreading methamphetamine use in Europe","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2022"},{"key":"pone.0292745.ref007","doi-asserted-by":"crossref","first-page":"e49897","DOI":"10.1371\/journal.pone.0049897","article-title":"Methamphetamine administration targets multiple immune subsets and induces phenotypic alterations suggestive of immunosuppression","volume":"7","author":"R Harms","year":"2012","journal-title":"PLoS One"},{"key":"pone.0292745.ref008","first-page":"445","article-title":"Impact of methamphetamine on infection and immunity","volume":"8","author":"SA Salamanca","year":"2014","journal-title":"Front Neurosci"},{"key":"pone.0292745.ref009","article-title":"Oral manifestations of illicit drug use","author":"L Teoh","year":"2019","journal-title":"Aust Dent J"},{"key":"pone.0292745.ref010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1601-0825.2008.01459.x","article-title":"Methamphetamine abuse and dentistry","volume":"15","author":"DT Hamamoto","year":"2009","journal-title":"Oral Dis"},{"key":"pone.0292745.ref011","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0740-5472(01)00215-X","article-title":"Drugs and sexual effects: role of drug type and gender","volume":"22","author":"RA Rawson","year":"2002","journal-title":"J Subst Abuse Treat"},{"key":"pone.0292745.ref012","first-page":"93","article-title":"Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users","volume":"168","author":"F Molitor","year":"1998","journal-title":"West J Med"},{"key":"pone.0292745.ref013","first-page":"273","article-title":"Methamphetamine use and HIV risk behaviors among heterosexual men\u2014preliminary results from five northern California counties, December 2001-November 2003","volume":"55","author":"Centers for Disease Control and Prevention (CDC)","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"pone.0292745.ref014","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1177\/0022042613491098","article-title":"Methamphetamine Use and Violent Behavior: User Perceptions and Predictors","volume":"43","author":"M-L Brecht","year":"2013","journal-title":"J Drug Issues"},{"key":"pone.0292745.ref015","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1360-0443.2009.02872.x","article-title":"Comparative rates of violent crime among regular methamphetamine and opioid users: offending and victimization","volume":"105","author":"S Darke","year":"2010","journal-title":"Addiction"},{"key":"pone.0292745.ref016","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/add.12474","article-title":"Does methamphetamine use increase violent behaviour? Evidence from a prospective longitudinal study","volume":"109","author":"R McKetin","year":"2014","journal-title":"Addiction"},{"key":"pone.0292745.ref017","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1177\/0306624X09351825","article-title":"Methamphetamine use and criminal behavior","volume":"54","author":"MC Gizzi","year":"2010","journal-title":"Int J Offender Ther Comp Criminol"},{"key":"pone.0292745.ref018","unstructured":"ABC Radio Perth. Number of crimes committed by methamphetamine addicts \u201ctruly frightening\u201d, WA\u2019s top judge says. 2015. Available: https:\/\/www.abc.net.au\/news\/2015-02-25\/wa-chief-justice-says-ice-problem-truly-frightening\/6261310"},{"key":"pone.0292745.ref019","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th edition). Washington (DC); 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"pone.0292745.ref020","first-page":"CD005336","article-title":"Psychosocial interventions for cannabis use disorder","author":"PJ Gates","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"pone.0292745.ref021","article-title":"Interventions for Substance Use Disorders in Adolescents: A Systematic Review","author":"D Steele","year":"2020","journal-title":"Agency for Healthcare Research and Quality"},{"key":"pone.0292745.ref022","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/sj.npp.1301481","article-title":"Bupropion for the treatment of methamphetamine dependence","volume":"33","author":"AM Elkashef","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"pone.0292745.ref023","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1111\/add.12636","article-title":"Randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use","volume":"109","author":"KG Heinzerling","year":"2014","journal-title":"Addiction"},{"key":"pone.0292745.ref024","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/archgenpsychiatry.2011.124","article-title":"Mirtazapine to reduce methamphetamine use: a randomized controlled trial","volume":"68","author":"GN Colfax","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"pone.0292745.ref025","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/jamapsychiatry.2019.3655","article-title":"Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men: A Placebo-Controlled Randomized Clinical Trial","volume":"77","author":"PO Coffin","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"pone.0292745.ref026","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drugalcdep.2018.04.023","article-title":"Varenicline treatment for methamphetamine dependence: A randomized, double-blind phase II clinical trial","volume":"189","author":"M Briones","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"pone.0292745.ref027","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1360-0443.2005.01002.x","article-title":"Brief cognitive behavioural interventions for regular amphetamine users: a step in the right direction","volume":"100","author":"A Baker","year":"2005","journal-title":"Addiction"},{"key":"pone.0292745.ref028","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.psychres.2005.12.003","article-title":"Contingency management: schedule effects","volume":"144","author":"JM Roll","year":"2006","journal-title":"Psychiatry Res"},{"key":"pone.0292745.ref029","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.addbeh.2013.03.018","article-title":"Duration effects in contingency management treatment of methamphetamine disorders","volume":"38","author":"JM Roll","year":"2013","journal-title":"Addict Behav"},{"key":"pone.0292745.ref030","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/10550887.2014.950029","article-title":"Randomized trial of intensive motivational interviewing for methamphetamine dependence","volume":"33","author":"DL Polcin","year":"2014","journal-title":"J Addict Dis"},{"key":"pone.0292745.ref031","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13643-020-01499-z","article-title":"Psychosocial and pharmacologic interventions for methamphetamine addiction: protocol for a scoping review of the literature","volume":"9","author":"C Hamel","year":"2020","journal-title":"Syst Rev"},{"key":"pone.0292745.ref032","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"H Arksey","year":"2005","journal-title":"International Journal of Social Research Methodology"},{"key":"pone.0292745.ref033","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation","volume":"169","author":"AC Tricco","year":"2018","journal-title":"Annals of Internal Medicine"},{"key":"pone.0292745.ref034","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/2046-4053-3-60","article-title":"Integration of existing systematic reviews into new reviews: identification of guidance needs","volume":"3","author":"KA Robinson","year":"2014","journal-title":"Syst Rev"},{"key":"pone.0292745.ref035","article-title":"Methodological Expectations of Cochrane Intervention Reviews (MECIR): Standards for the conduct and reporting of new Cochrane Intervention Reviews, reporting of protocols and the planning, conduct and reporting of updates","author":"J. Higgins","year":"2019"},{"key":"pone.0292745.ref036","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-156-7-201204030-00009","article-title":"Guidelines International Network: toward international standards for clinical practice guidelines","volume":"156","author":"A Qaseem","year":"2012","journal-title":"Ann Intern Med"},{"key":"pone.0292745.ref037","volume-title":"Clinical Practice Guidelines We Can Trust","author":"Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines","year":"2011"},{"key":"pone.0292745.ref038","unstructured":"Canadian Agency for Drugs and Technologies in Health (CADTH). Grey matters: a practical search tool for evidenced\u2010based medicine. Dec 2015. Available: https:\/\/www.cadth.ca\/resources\/finding-evidence\/grey-matters"},{"key":"pone.0292745.ref039","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2046-4053-1-10","article-title":"Evidence summaries: the evolution of a rapid review approach","volume":"1","author":"S Khangura","year":"2012","journal-title":"Syst Rev"},{"key":"pone.0292745.ref040","volume-title":"Part 2: General methods for Cochrane reviews","author":"JPT Higgins","year":"2011"},{"key":"pone.0292745.ref041","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"BJ Shea","year":"2017","journal-title":"BMJ"},{"key":"pone.0292745.ref042","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ypmed.2010.08.005","article-title":"AGREE II: advancing guideline development, reporting, and evaluation in health care","volume":"51","author":"MC Brouwers","year":"2010","journal-title":"Prev Med"},{"key":"pone.0292745.ref043","author":"JE McKenzie","year":"2020"},{"key":"pone.0292745.ref044","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","article-title":"Simultaneous comparison of multiple treatments: combining direct and indirect evidence","volume":"331","author":"D Caldwell","year":"2005","journal-title":"BMJ"},{"key":"pone.0292745.ref045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1741-7015-12-93","article-title":"A process for assessing the feasibility of a network meta-analysis: a case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer","volume":"12","author":"S Cope","year":"2014","journal-title":"BMC Med"},{"key":"pone.0292745.ref046","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2019.04.010","article-title":"Effectiveness of methamphetamine abuse treatment: Predictors of treatment completion and comparison of two residential treatment programs","volume":"201","author":"F Kamp","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"pone.0292745.ref047","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/14659891.2018.1549279","article-title":"Efficacy of the Marlatt cognitive-behavioral model on decreasing relapse and craving in women with methamphetamine dependence: A clinical trial","volume":"24","author":"N Abdoli","year":"2019","journal-title":"Journal of Substance Use"},{"key":"pone.0292745.ref048","first-page":"77","article-title":"Evaluating the efficacy of Regulated 12-Session Matrix Model in reducing susceptibility in methamphetamine-dependent individuals","volume":"5","author":"Z Amiri","year":"2016","journal-title":"International Journal of Medical Research & Health Sciences"},{"key":"pone.0292745.ref049","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drugalcdep.2011.07.007","article-title":"Modafinil for the treatment of methamphetamine dependence","volume":"120","author":"AL Anderson","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"pone.0292745.ref050","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.drugalcdep.2015.01.036","article-title":"Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial","volume":"150","author":"AL Anderson","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"pone.0292745.ref051","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jad.2012.05.006","article-title":"A randomized, double-blind, placebo-controlled trial of citicoline for bipolar and unipolar depression and methamphetamine dependence","volume":"143","author":"ES Brown","year":"2012","journal-title":"J Affect Disord"},{"key":"pone.0292745.ref052","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40732-014-0110-3","article-title":"Reinforcement Schedule Effects on Long-Term Behavior Change","volume":"65","author":"J Chudzynski","year":"2015","journal-title":"Psychol Rec"},{"key":"pone.0292745.ref053","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/17523281.2012.713390","article-title":"Health-related quality of life (HRQL) among methamphetamine users in treatment","volume":"6","author":"S Ciketic","year":"2013","journal-title":"Mental Health and Substance Use"},{"key":"pone.0292745.ref054","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/add.12073","article-title":"Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial","volume":"108","author":"PO Coffin","year":"2013","journal-title":"Addiction"},{"key":"pone.0292745.ref055","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/add.13950","article-title":"Extended-release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo-controlled trial","volume":"113","author":"PO Coffin","year":"2018","journal-title":"Addiction"},{"key":"pone.0292745.ref056","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/QAD.0b013e328336e98b","article-title":"Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high-risk men who have sex with men","volume":"24","author":"M Das","year":"2010","journal-title":"AIDS"},{"key":"pone.0292745.ref057","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1360-0443.2011.03771.x","article-title":"Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial","volume":"107","author":"A Elkashef","year":"2012","journal-title":"Addiction"},{"key":"pone.0292745.ref058","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/0269881118817166","article-title":"Riluzole for treatment of men with methamphetamine dependence: A randomized, double-blind, placebo-controlled clinical trial","volume":"33","author":"M-H Farahzadi","year":"2019","journal-title":"J Psychopharmacol"},{"key":"pone.0292745.ref059","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0740-5472(96)00154-7","article-title":"A controlled trial of imipramine for the treatment of methamphetamine dependence","volume":"13","author":"GP Galloway","year":"1996","journal-title":"J Subst Abuse Treat"},{"key":"pone.0292745.ref060","doi-asserted-by":"crossref","first-page":"e20024","DOI":"10.5812\/ircmj.20024","article-title":"Effects of Educational Intervention on Health-Promoting Lifestyle and Health-Related Life quality of Methamphetamine Users and Their Families: a Randomized Clinical Trial","volume":"16","author":"A Ghasemi","year":"2014","journal-title":"Iran Red Crescent Med J"},{"key":"pone.0292745.ref061","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.drugalcdep.2006.03.019","article-title":"Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence","volume":"85","author":"KG Heinzerling","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"pone.0292745.ref062","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.drugalcdep.2009.11.023","article-title":"Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence","volume":"109","author":"KG Heinzerling","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"pone.0292745.ref063","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s11481-019-09883-w","article-title":"Randomized, Placebo-Controlled Trial of Targeting Neuroinflammation with Ibudilast to Treat Methamphetamine Use Disorder","volume":"15","author":"KG Heinzerling","year":"2020","journal-title":"J Neuroimmune Pharmacol"},{"key":"pone.0292745.ref064","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4103\/2277-9175.187404","article-title":"Effect of add-on valproate on craving in methamphetamine depended patients: A randomized trial","volume":"5","author":"GR Kheirabadi","year":"2016","journal-title":"Adv Biomed Res"},{"key":"pone.0292745.ref065","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1360-0443.2011.03619.x","article-title":"Double-blind placebo-controlled evaluation of the PROMETATM protocol for methamphetamine dependence","volume":"107","author":"W Ling","year":"2012","journal-title":"Addiction"},{"key":"pone.0292745.ref066","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/add.12608","article-title":"Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder","volume":"109","author":"W Ling","year":"2014","journal-title":"Addiction"},{"key":"pone.0292745.ref067","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1360-0443.2009.02717.x","article-title":"Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence","volume":"105","author":"M Longo","year":"2010","journal-title":"Addiction"},{"key":"pone.0292745.ref068","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/09540121.2019.1595518","article-title":"An initial randomized controlled trial of behavioral activation for treatment of concurrent crystal methamphetamine dependence and sexual risk for HIV acquisition among men who have sex with men","volume":"31","author":"MJ Mimiaga","year":"2019","journal-title":"AIDS Care"},{"key":"pone.0292745.ref069","first-page":"110","article-title":"Methamphetamine dependence treatment rehabilitation in Thailand: a model assessment","volume":"94","author":"U Perngparn","year":"2011","journal-title":"J Med Assoc Thai"},{"key":"pone.0292745.ref070","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1360-0443.2004.00707.x","article-title":"A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence","volume":"99","author":"RA Rawson","year":"2004","journal-title":"Addiction"},{"key":"pone.0292745.ref071","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jsat.2018.06.005","article-title":"Ecological momentary assessments for self-monitoring and counseling to optimize methamphetamine treatment and sexual risk reduction outcomes among gay and bisexual men","volume":"92","author":"CJ Reback","year":"2018","journal-title":"J Subst Abuse Treat"},{"key":"pone.0292745.ref072","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1176\/ajp.2006.163.11.1993","article-title":"Contingency management for the treatment of methamphetamine use disorders","volume":"163","author":"JM Roll","year":"2006","journal-title":"Am J Psychiatry"},{"key":"pone.0292745.ref073","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10461-018-2225-z","article-title":"Theory-Based Text-Messaging to Reduce Methamphetamine Use and HIV Sexual Risk Behaviors Among Men Who Have Sex with Men: Automated Unidirectional Delivery Outperforms Bidirectional Peer Interactive Delivery","volume":"23","author":"CJ Reback","year":"2019","journal-title":"AIDS Behav"},{"key":"pone.0292745.ref074","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF03395538","article-title":"A Comparison of Five Reinforcement Schedules for use in Contingency Management-Based Treatment of Methamphetamine Abuse","volume":"56","author":"JM Roll","year":"2006","journal-title":"Psychol Rec"},{"key":"pone.0292745.ref075","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/JCP.0000000000000408","article-title":"The Effect of Buprenorphine on Methamphetamine Cravings","volume":"35","author":"M Salehi","year":"2015","journal-title":"J Clin Psychopharmacol"},{"key":"pone.0292745.ref076","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1360-0443.2008.02437.x","article-title":"A double-blind, placebo-controlled trial of modafinil (200 mg\/day) for methamphetamine dependence","volume":"104","author":"J Shearer","year":"2009","journal-title":"Addiction"},{"key":"pone.0292745.ref077","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.drugalcdep.2004.10.004","article-title":"Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men","volume":"78","author":"S Shoptaw","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"pone.0292745.ref078","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drugalcdep.2006.03.005","article-title":"Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence","volume":"85","author":"S Shoptaw","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"pone.0292745.ref079","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jsat.2007.11.004","article-title":"Outcomes using two tailored behavioral treatments for substance abuse in urban gay and bisexual men","volume":"35","author":"S Shoptaw","year":"2008","journal-title":"J Subst Abuse Treat"},{"key":"pone.0292745.ref080","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.03.010","article-title":"Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence","volume":"96","author":"S Shoptaw","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"pone.0292745.ref081","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/08897071003641578","article-title":"Psychosocial treatment for methamphetamine use disorders: a preliminary randomized controlled trial of cognitive behavior therapy and Acceptance and Commitment Therapy","volume":"31","author":"MF Smout","year":"2010","journal-title":"Subst Abus"},{"key":"pone.0292745.ref082","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa2020214","article-title":"Bupropion and Naltrexone in Methamphetamine Use Disorder","volume":"384","author":"MH Trivedi","year":"2021","journal-title":"N Engl J Med"},{"key":"pone.0292745.ref083","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3389\/fpsyt.2019.00656","article-title":"Paliperidone Extended-Release Tablets for the Treatment of Methamphetamine Use Disorder in Chinese Patients After Acute Treatment: A Randomized, Double-Blind, Placebo-Controlled Exploratory Study","volume":"10","author":"G Wang","year":"2019","journal-title":"Front Psychiatry"},{"key":"pone.0292745.ref084","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1465-3362.2012.00423.x","article-title":"Cigarette smoking as a target for potentiating outcomes for methamphetamine abuse treatment","volume":"32","author":"M Brensilver","year":"2013","journal-title":"Drug Alcohol Rev"},{"key":"pone.0292745.ref085","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1037\/1064-1297.15.3.301","article-title":"Depression ratings, reported sexual risk behaviors, and methamphetamine use: latent growth curve models of positive change among gay and bisexual men in an outpatient treatment program","volume":"15","author":"A Jaffe","year":"2007","journal-title":"Exp Clin Psychopharmacol"},{"key":"pone.0292745.ref086","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jsat.2013.08.013","article-title":"Intensive motivational interviewing for women with concurrent alcohol problems and methamphetamine dependence","volume":"46","author":"RA Korcha","year":"2014","journal-title":"J Subst Abuse Treat"},{"key":"pone.0292745.ref087","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jsat.2009.12.006","article-title":"It\u2019s the thought that counts: craving metacognitions and their role in abstinence from methamphetamine use","volume":"38","author":"NK Lee","year":"2010","journal-title":"J Subst Abuse Treat"},{"key":"pone.0292745.ref088","first-page":"S38","article-title":"The influence of depression on treatment for methamphetamine use","volume":"195","author":"FJ Kay-Lambkin","year":"2011","journal-title":"Med J Aust"},{"key":"pone.0292745.ref089","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.drugalcdep.2012.10.009","article-title":"Fine-grain analysis of the treatment effect of topiramate on methamphetamine addiction with latent variable analysis","volume":"130","author":"JZ Ma","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"pone.0292745.ref090","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1755-5949.2011.00263.x","article-title":"A novel, nonbinary evaluation of success and failure reveals bupropion efficacy versus methamphetamine dependence: reanalysis of a multisite trial","volume":"18","author":"DJ McCann","year":"2012","journal-title":"CNS Neurosci Ther"},{"key":"pone.0292745.ref091","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1111\/j.1360-0443.2012.03933.x","article-title":"Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES)","volume":"107","author":"R McKetin","year":"2012","journal-title":"Addiction"},{"key":"pone.0292745.ref092","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/dar.12528","article-title":"Predicting abstinence from methamphetamine use after residential rehabilitation: Findings from the Methamphetamine Treatment Evaluation Study","volume":"37","author":"R McKetin","year":"2018","journal-title":"Drug Alcohol Rev"},{"key":"pone.0292745.ref093","doi-asserted-by":"crossref","first-page":"i100","DOI":"10.1093\/jurban\/jti029","article-title":"Sustained reductions in drug use and depression symptoms from treatment for drug abuse in methamphetamine-dependent gay and bisexual men","volume":"82","author":"JA Peck","year":"2005","journal-title":"J Urban Health"},{"key":"pone.0292745.ref094","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jsat.2007.11.003","article-title":"Methamphetamine dependence and human immunodeficiency virus risk behavior","volume":"35","author":"RA Rawson","year":"2008","journal-title":"J Subst Abuse Treat"},{"key":"pone.0292745.ref095","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/02791072.2012.718653","article-title":"Process-of-care measures as predictors of client outcome among a methamphetamine-dependent sample at 12- and 36-month follow-ups","volume":"44","author":"RA Rawson","year":"2012","journal-title":"J Psychoactive Drugs"},{"key":"pone.0292745.ref096","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1465-3362.2009.00148.x","article-title":"A cost-effectiveness analysis of modafinil therapy for psychostimulant dependence","volume":"29","author":"J Shearer","year":"2010","journal-title":"Drug Alcohol Rev"},{"key":"pone.0292745.ref097","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.drugalcdep.2011.04.015","article-title":"Poor response to sertraline in methamphetamine dependence is associated with sustained craving for methamphetamine","volume":"118","author":"T Zorick","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"pone.0292745.ref098","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/JCP.0000000000001320","article-title":"The Effect of Add-on Buprenorphine to Matrix Program in Reduction of Craving and Relapse Among People With Methamphetamine Use Disorder: A Randomized Controlled Trial","volume":"41","author":"GR Kheirabadi","year":"2021","journal-title":"J Clin Psychopharmacol"},{"key":"pone.0292745.ref099","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/14659891.2020.1851406","article-title":"The effect of self-compassion training on craving and self-efficacy in female patients with methamphetamine dependence: a one-year follow-up","volume":"26","author":"N Abdoli","year":"2021","journal-title":"Journal of Substance Use"},{"key":"pone.0292745.ref100","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.4314\/tjpr.v19i10.23","article-title":"Role of modafinil in the treatment of patients with methamphetamine dependence; An update on randomized, controlled clinical trial","volume":"19","author":"MT Fard","year":"2020","journal-title":"Trop J Pharm Res"},{"key":"pone.0292745.ref101","doi-asserted-by":"crossref","first-page":"101005","DOI":"10.1016\/j.eclinm.2021.101005","article-title":"N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial","volume":"38","author":"R McKetin","year":"2021","journal-title":"EClinicalMedicine"},{"key":"pone.0292745.ref102","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13722-020-00209-3","article-title":"A novel brief treatment for methamphetamine use disorders in South Africa: a randomised feasibility trial","volume":"16","author":"K Sorsdahl","year":"2021","journal-title":"Addict Sci Clin Pract"},{"key":"pone.0292745.ref103","first-page":"137","article-title":"Adding extended-release methylphenidate to psychological intervention for treatment of methamphetamine dependence: A double-blind randomized controlled trial","volume":"34","author":"A Noroozi","year":"2020","journal-title":"Med J Islam Repub Iran"},{"key":"pone.0292745.ref104","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13011-020-00317-y","article-title":"The therapeutic effects of methylphenidate and matrix-methylphenidate on addiction severity, craving, relapse and mental health in the methamphetamine use disorder","volume":"15","author":"N Aryan","year":"2020","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"pone.0292745.ref105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jpsychires.2020.05.029","article-title":"12- and 18-month follow-up after residential treatment of methamphetamine dependence: Influence of treatment drop-out and different treatment concepts","volume":"129","author":"F Kamp","year":"2020","journal-title":"J Psychiatr Res"},{"key":"pone.0292745.ref106","volume-title":"S3 practice guideline methamphetamine-related disorders","author":"WD Braunwarth","year":"2016"},{"key":"pone.0292745.ref107","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1055\/s-0043-105500","article-title":"Evidence-Based Guidelines for the Pharmacologic Management of Methamphetamine Dependence, Relapse Prevention, Chronic Methamphetamine-Related, and Comorbid Psychiatric Disorders in Post-Acute Settings","volume":"50","author":"R H\u00e4rtel-Petri","year":"2017","journal-title":"Pharmacopsychiatry"},{"key":"pone.0292745.ref108","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13643-016-0370-x","article-title":"Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysis","volume":"5","author":"M Bhatt","year":"2016","journal-title":"Syst Rev"},{"key":"pone.0292745.ref109","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s40263-020-00780-y","article-title":"Use of Topiramate in the Spectrum of Addictive and Eating Disorders: A Systematic Review Comparing Treatment Schemes, Efficacy, and Safety Features","volume":"35","author":"M Nourredine","year":"2021","journal-title":"CNS Drugs"},{"key":"pone.0292745.ref110","unstructured":"Grigg J, Manning V, Arunogiri S et al. Methamphetamine Treatment Guidelines: Practice Guidelines for Health Professionals (2nd edition). Australia; 2018. Available: https:\/\/www.turningpoint.org.au\/sites\/default\/files\/2019-05\/Turning-Point-Methamphetamine-Treatment-Guidelines.pdf"},{"key":"pone.0292745.ref111","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13063-017-1978-4","article-title":"The COMET Handbook: version 1.0","volume":"18","author":"PR Williamson","year":"2017","journal-title":"Trials"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0292745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T17:33:43Z","timestamp":1697045623000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0292745"}},"subtitle":[],"editor":[{"given":"Giuseppe","family":"Carr\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":111,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0292745","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,11]]}}}